Hyderabad, December 5, 2022:

MapMyGenome, a preventive genomics company, has launched its pharmacogenomics solution MedicaMap on Sunday.

MedicaMap is a cutting-edge pharmacogenomic solution that analyses an individual’s response to medicines based on genetic makeup. The pharmacogenomic solution can analyse over 165 US-FDA-approved drugs across 12 different specialties such as psychiatry, oncology, cardiology and diabetology.

MedicaMap give an easy-to-read comprehensive report on medicines‘ toxicity and efficacy for a person. It guides clinicians to identify alternate medicine or adjust the dosage according to an individual‘s genetic profile for the prevention, diagnosis, and treatment of any health condition.

The MedicaMap covers common medicines like metformin, clopidogrel, warfarin, codeine, and other medicines commonly used by Indians. It gives an easy-to-read comprehensive report on medicines’ toxicity and efficacy for a person. It also helps clinicians to identify alternate medicine or adjust the dosage according to an individual’s genetic profile for the prevention, diagnosis, and treatment of any health condition.